Search

for
Search:

Learn

0 / 0 results

— no results

Research

4 / 4 results

research Bendamustine: An Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia

9 citations , January 2018 in “Acta Clinica Croatica”

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

research Bendamustine in Indolent Non-Hodgkin's Lymphoma: A Practice Guide for Patient Management

24 citations , July 2013 in “Oncologist”

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

research Toll-Like Receptor-Targeted Anti-Tumor Therapies: Advances and Challenges

44 citations , November 2022 in “Frontiers in Immunology”

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

research Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases

2 citations , October 2022 in “Current Allergy and Asthma Reports”

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Community Join

0 / 0 results

— no results